Streetdrugs
2255 North Willow Dr.
Long Lake, MN 55356.
(763) 473-0646
info@streetdrugs.org
MENUMENU

Sibutramine

On October 8, 2010, the U.S. Food and Drug Administration (FDA) asked Abbott Laboratories to voluntarily withdraw Meridia from the U.S. market, its weight loss drug Meridia (sibutramine) because of clinical trial data indicating an increased risk of cardiovascular adverse events, including heart attack and stroke, in the studied population. Abbott has agreed to voluntarily stop the marketing of Meridia in the United States.

Source: FDA

Other Sources

Drug Identification Guide

CDC Facts

CDC Addiction Info

CDC Overdose Stats

CDC Substance Treatment

Whitehouse Drug-Free Communities

Samhsa Workplace Programs

Drug-Free

Federal Register Codification

Leave a Reply

Your email address will not be published. Required fields are marked *

© Copyright 2019 - Streetdrugs.org - All Rights Reserved
phoneenvelopelocation-arrow

Newsletter Signup

Sign up now and never miss a thing!

You're Signed Up!

Now that you are signed up, we will send you exclusive offers periodically.

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram